In the low-expression adjuvant tamoxifen group, one patient had a recurrence of BC and another 10 patients exhibited no recurrence, while six showed recurrence and seven had none in the high expression group, thus indicating that serum EV HOTAIR exhibits the potential to be a diagnostic, prognostic and predictive biomarker in BC [182]. Here, HOTAIR is linked to breast cancer.